• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form S-8 filed by Gevo Inc.

    6/5/25 7:38:48 PM ET
    $GEVO
    Major Chemicals
    Industrials
    Get the next $GEVO alert in real time by email
    S-8 1 tm2516296d1_s8.htm FORM S-8

     

    As filed with the Securities and Exchange Commission on June 5, 2025

     

    Registration No. 333-

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

     

    FORM S-8

     

    REGISTRATION STATEMENT UNDER THE

    SECURITIES ACT OF 1933

     

     

     

    GEVO, INC.
    (Exact name of registrant as specified in its charter)

     

    Delaware 87-0747704

    (State or other jurisdiction of

    incorporation or organization)

    (I.R.S. Employer

    Identification No.)

     

    345 Inverness Drive South, Building C, Suite 310

    Englewood, Colorado

    (Address of principal executive offices)

     

    80112

     

    (Zip code)

     

    Gevo, Inc. Amended and Restated 2010 Stock Incentive Plan
    (Full title of the plan)

     

    Patrick R. Gruber

    Chief Executive Officer

    Gevo, Inc.

    345 Inverness Drive South, Building C, Suite 310

    Englewood, Colorado 80112

     

    (Name and address of agent for service)

     

    (303) 858-8358

    (Telephone number, including area code, of agent for service)

     

     

    Copy to:

     

    Jason Day

    Ned A. Prusse

    Perkins Coie LLP

    1900 Sixteenth Street, Suite 1400

    Denver, Colorado 80202-5255

    (303) 291-2300

     

    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act:

     

    Large accelerated filer ¨   Accelerated filer ¨
    Non-accelerated filer x   Smaller reporting company x
      Emerging growth company ¨

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ¨

     

     

     

     

     

     

    EXPLANATORY NOTE

     

    This registration statement on Form S-8 is filed by Gevo, Inc. relating to 15,000,000 additional shares of common stock, par value $0.01 per share, authorized to be issued pursuant to the Gevo, Inc. Amended and Restated 2010 Stock Incentive Plan.

     

    PART II

     

    INFORMATION REQUIRED IN REGISTRATION STATEMENT

     

    Item 3.Incorporation of Documents by Reference.

     

    The following documents filed with the Securities and Exchange Commission (the “SEC”) are hereby incorporated by reference in this registration statement:

     

    (a)The registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024, filed with the SEC on March 27, 2025;

     

    (b)The registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2025, filed with the SEC on May 13, 2025;

     

    (c)The registrant’s Current Reports on Form 8-K filed with the SEC on January 15, 2025, February 3, 2025, March 20, 2025, April 9, 2025, April 16, 2025 and May 27, 2025(excluding any reports or portions of such reports that are furnished under Item 2.02 or Item 7.01 and any exhibits included with such Items); and

     

    (d)The description of the registrant’s common stock contained in Exhibit 4.3 to the registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021, filed with the SEC on February 24, 2022.

     

    All documents filed by the registrant pursuant to Section 13(a), 13(c), 14 or 15(d) of the Securities Exchange Act of 1934, as amended, after the date hereof, and prior to the filing of a post-effective amendment that indicates that all the securities offered hereby have been sold or that deregisters the securities offered hereby then remaining unsold, shall also be deemed to be incorporated by reference into this registration statement and to be a part hereof from the date of filing of such documents; provided, however, that documents or information deemed to have been furnished and not filed in accordance with the rules of the SEC shall not be deemed incorporated by reference in this registration statement.

     

    Item 4.Description of Securities.

     

    Not applicable.

     

    Item 5.Interests of Named Experts and Counsel.

     

    None.

     

    Item 6.Indemnification of Directors and Officers.

     

    Under Section 145 of the Delaware General Corporation Law (the “DGCL”), a corporation has the power to indemnify its directors and officers under certain prescribed circumstances and, subject to certain limitations, against certain costs and expenses, including attorneys’ fees, judgments, fines and amounts paid in settlement, actually and reasonably incurred in connection with any threatened, pending or completed action, suit or proceeding, whether criminal, civil, administrative or investigative, to which any of them is a party by reason of his being a director or officer of the corporation if it is determined that he acted in accordance with the applicable standard of conduct set forth in such statutory provision. In addition, a corporation may advance expenses incurred by a director or officer in defending a proceeding upon receipt of an undertaking from such person to repay any amount so advanced if it is ultimately determined that such person is not eligible for indemnification. The registrant’s amended and restated certificate of incorporation provides that, pursuant to the DGCL, the registrant’s directors shall not be liable for monetary damages to the fullest extent authorized under applicable law, including for breach of the directors’ fiduciary duty of care to the registrant and the registrant’s stockholders. This provision in the registrant’s amended and restated certificate of incorporation does not eliminate the duty of care, and in appropriate circumstances equitable remedies such as injunctive or other forms of non-monetary relief will remain available under Delaware law. In addition, each director will continue to be subject to liability for breach of the director’s duty of loyalty, for acts or omissions not in good faith or involving intentional misconduct or knowing violations of the law, for actions leading to improper personal benefit to the director, and for payment of dividends or approval of stock repurchases or redemptions that are unlawful under Delaware law. The provision also does not affect a director’s responsibilities under any other law, such as the federal securities laws or state or federal environmental laws.

     

     

     

     

    Article 10 of the registrant’s second amended and restated bylaws provides that the registrant will indemnify, to the fullest extent authorized by the DGCL, each person who was or is made a party or is threatened to be made a party to or is otherwise involved in any action, suit or proceeding, whether civil, criminal, administrative or investigative, by reason of the fact that he or she, or a person for whom he or she is the legal representative, is or was a director or officer of the registrant, or is or, while a director or officer of the registrant, was serving at the request of the registrant as a director, officer, employee, agent or trustee of another corporation or of a partnership, joint venture, trust or other enterprise, including service with respect to an employee benefit plan, whether the basis of such proceeding is alleged action in an official capacity as a director, officer, employee, agent or trustee or in any other capacity while serving as a director, officer, employee, agent or trustee, against all expenses, liability and loss (including attorneys’ fees, judgments, fines, ERISA excise taxes or penalties and amounts paid in settlement) reasonably incurred or suffered by such person in connection therewith.

     

    In addition to the above, the registrant has entered into indemnification agreements with each of the registrant’s directors and officers. These indemnification agreements provide the registrant’s directors and officers with the same indemnification and advancement of expenses as described above, and provide that the registrant’s directors and officers will be indemnified to the fullest extent authorized by any future Delaware law that expands the permissible scope of indemnification. The registrant also has directors’ and officers’ liability insurance, which provides coverage against certain liabilities that may be incurred by the registrant’s directors and officers in their capacities as directors and officers of the registrant.

     

    Item 7.Exemption from Registration Claimed.

     

    Not applicable.

     

    Item 8.Exhibits.

     

    Exhibit No.   Description
    5.1   Opinion of Perkins Coie LLP.
    23.1   Consent of Deloitte & Touche LLP.
    23.2   Consent of Grant Thornton LLP.
    23.3   Consent of Eide Bailly LLP.
    23.4   Consent of Perkins Coie LLP (included in Exhibit 5.1).
    24.1   Power of Attorney (see signature page).
    99.1   Gevo, Inc. Amended and Restated 2010 Stock Incentive Plan (incorporated by reference to Exhibit 10.1 of the registrant’s Current Report on Form 8-K filed on May 27, 2025).  
    107   Filing Fee Table.

     

    Item 9.Undertakings.

     

    A. The undersigned registrant hereby undertakes:

     

    (1) To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:

     

    (a) To include any prospectus required by Section 10(a)(3) of the Securities Act;

     

    (b) To reflect in the prospectus any facts or events arising after the effective date of this registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in this registration statement; and

     

     

     

     

    (c) To include any material information with respect to the plan of distribution not previously disclosed in this registration statement or any material change to such information in this registration statement;

     

    provided, however, that paragraphs (1)(a) and (1)(b) above do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the registrant pursuant to Section 13 or Section 15(d) of the Exchange Act that are incorporated by reference in this registration statement.

     

    (2) That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

     

    (3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.

     

    B. The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the registrant’s annual report pursuant to Section 13(a) or 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan’s annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in this registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

     

    C. Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that, in the opinion of the SEC, such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Englewood, State of Colorado, on June 5, 2025.

     

      GEVO, INC.
         
      By: /s/ Patrick R. Gruber
        Patrick R. Gruber
        Chief Executive Officer

     

    POWER OF ATTORNEY

     

    Each person whose individual signature appears below hereby authorizes Patrick R. Gruber, Oluwagbemileke Y. Agiri and E. Cabell Massey, or either of them, as attorneys-in-fact, with full power of substitution, to execute in the name and on the behalf of each person, individually and in each capacity stated below, and to file, any and all amendments to this Registration Statement, including any and all post-effective amendments.

     

    Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated.

     

    Signature

    Title

    Date

    /s/ Patrick R. Gruber Chief Executive Officer (Principal Executive
    Officer
    ) and Director
    June 5, 2025
    Patrick R. Gruber    
    /s/ Leke Agiri

    Chief Financial Officer

    (Principal Financial Officer)

    June 5, 2025
    Leke Agiri    
    /s/ Sylvia Gendenjamts Vice President Accounting and Treasurer
    (Principal Accounting Officer)
    June 5, 2025
    Sylvia Gendenjamts    
    /s/ William H. Baum

     

    Chairman of the Board of Directors

    June 5, 2025
    William H. Baum    
         
    /s/ Angelo Amorelli Director June 5, 2025
    Angelo Amorelli    
         
    /s/ James J. Barber Director June 5, 2025
    James J. Barber    
         
    /s/ Carol Battershell Director June 5, 2025
    Carol Battershell    
         
    /s/ Mary Kathryn Ellet Director June 5, 2025
    Mary Kathryn Ellet    
         
    /s/ Jaime Guillen Director June 5, 2025
    Jaime Guillen    
         
    /s/ Andrew J. Marsh Director June 5, 2025
    Andrew J. Marsh    
         
    /s/ Gary W. Mize Director June 5, 2025
    Gary W. Mize    

     

     

     

    Get the next $GEVO alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $GEVO

    DatePrice TargetRatingAnalyst
    8/21/2023$2.00Market Perform
    Northland Capital
    12/14/2022$2.25Neutral
    UBS
    10/19/2022$2.29Hold
    Jefferies
    2/9/2022$5.00Buy
    Citigroup
    8/24/2021$10.00Buy
    Stifel
    More analyst ratings

    $GEVO
    Leadership Updates

    Live Leadership Updates

    See more
    • Gevo Appoints Industry Veteran James Barber, Ph.D. to Board of Directors

      ENGLEWOOD, Colo., May 27, 2025 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ:GEVO), a leader in sustainable aviation fuel and renewable chemicals, announced today the appointment of James J. Barber, Ph.D., to its Board of Directors. Dr. Barber brings decades of executive leadership and board experience in public and private companies including fuels, chemicals, biobased materials, micro-optics, carbon nanofibers, joint ventures and licensing. Dr. Barber currently serves on the board of directors of Graham Corporation (NYSE:GHM), where he chairs the Compensation Committee and is a member of the Audit and Nomination and Governance Committees. Dr. Barber holds a Ph.D. in Organic Chemistry from the

      5/27/25 4:10:00 PM ET
      $GEVO
      $GHM
      Major Chemicals
      Industrials
      Industrial Machinery/Components
    • Gevo Promotes Leke Agiri to Chief Financial Officer

      ENGLEWOOD, Colo., May 27, 2025 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ:GEVO), is pleased to announce the appointment of Oluwagbemileke (Leke) Agiri as Chief Financial Officer, effective as of May 21, 2025. Mr. Agiri succeeds L. Lynn Smull, who will continue with the Company in a new role as Executive Vice President and Senior Advisor to the Chief Executive Officer, focusing on strategic initiatives and to aide and support a seamless transition. Mr. Agiri brings extensive experience and leadership in corporate finance, capital markets, and strategic growth, both organic and inorganic. Since joining Gevo in August 2022, he has served in key leadership roles, most recently as Executive Vice P

      5/27/25 4:01:00 PM ET
      $GEVO
      Major Chemicals
      Industrials
    • Gevo Announces Appointment of Katie Ellet to Board of Directors

      ENGLEWOOD, Colo., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ:GEVO) is pleased to announce that Katie Ellet has been appointed to its board of directors as of January 2, 2024. Ms. Ellet serves as president, Hydrogen Energy and Mobility for North America at Air Liquide, a world leader in gases, technologies and services for Industry and Health, and a global innovator in low carbon hydrogen production. She has held a wide variety of leadership roles in the chemical and energy fields for the last 27 years. "We are honored to have Katie join our Board of Directors," said Dr. Patrick Gruber, CEO of Gevo. "She has a demonstrated record of technology expertise, market knowledge, and inn

      1/3/24 4:05:00 PM ET
      $GEVO
      Major Chemicals
      Industrials

    $GEVO
    Financials

    Live finance-specific insights

    See more

    $GEVO
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Gevo Reports First Quarter 2025 Financial Results

      Quarterly Revenue Increased $25 Million Compared to First Quarter of 2024 Due to Strategic Growth Initiatives  Further Revenue and Adjusted EBITDA1 Growth is Expected in 2025  Gevo to Host Conference Call Today at 4:30 p.m. ET ENGLEWOOD, Colo., May 13, 2025 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ:GEVO) ("Gevo", the "Company", "we", "us" or "our"), a leading developer of cost-effective, renewable hydrocarbon fuels and chemicals that also can deliver significant carbon emission abatement, today announced financial results for the first quarter ended March 31, 2025. Recent Corporate Highlights: Continuing on a Path to Positive Adjusted EBITDA1  Revenue and Adjusted EBITDA growth: Total op

      5/13/25 4:01:00 PM ET
      $GEVO
      Major Chemicals
      Industrials
    • Gevo to Report First Quarter 2025 Financial Results on May 13, 2025

      ENGLEWOOD, Colo., April 29, 2025 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ:GEVO) announced today that it will host a conference call on May 13, 2025, at 4:30 p.m. ET (2:30 p.m. MT) to report its financial results for the first quarter ended March 31, 2025. To participate in the live call, please register through the following event weblink: https://register-conf.media-server.com/register/BI14d4db26011d45b9871ce05b8b3c5a63   After registering, participants will be provided with a dial-in number and pin. To listen to the conference call (audio only), please register through the following event weblink: https://edge.media-server.com/mmc/p/xd9v2i3x   A webcast replay will be available two hou

      4/29/25 9:30:00 AM ET
      $GEVO
      Major Chemicals
      Industrials
    • Gevo Reports Fourth Quarter 2024 Financial Results and Reaffirms Business Update

      ENGLEWOOD, Colo., March 27, 2025 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ:GEVO) ("Gevo", the "Company", "we", "us" or "our"), a leading developer of cost effective, renewable hydrocarbon fuels and chemicals with reduced greenhouse gas emissions, today announced financial results for the fourth quarter and full year ended December 31, 2024, and reaffirmed the Business Update that was released on March 7, 2025 (the "Business Update"), which is available on our website at https://investors.gevo.com/news-releases/news-release-details/gevo-provides-business-update-1. 2024 Fourth Quarter Financial Highlights Ended the fourth quarter with cash, cash equ

      3/27/25 4:01:00 PM ET
      $GEVO
      Major Chemicals
      Industrials
    • Gevo Promotes Lindsay Fitzgerald to Chief Advocacy and Communications Officer

      ENGLEWOOD, Colo., June 03, 2025 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ:GEVO) announced today the promotion of Lindsay Fitzgerald to Chief Advocacy and Communications Officer, effective immediately. In this expanded leadership role, Ms. Fitzgerald will focus on advancing Gevo's mission to strengthen American energy and food security by unlocking the full value of U.S. agriculture and rural communities. She continues to drive policy advocacy and public communications that support cost-effective, American-made hydrocarbon fuels and chemicals, while building free-market solutions for carbon abatement and economic growth. Her efforts help bolster U.S. agriculture as the most sustainable in the

      6/3/25 4:01:00 PM ET
      $GEVO
      Major Chemicals
      Industrials
    • Gevo to Sell Luverne, Minnesota Ethanol Facility to A.E. Innovation; Will Retain Isobutanol Assets for Future Innovation

      ENGLEWOOD, Colo., May 28, 2025 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ:GEVO) is pleased to announce that it has entered into a definitive agreement to sell Agri-Energy, LLC ("Agri"), a wholly owned subsidiary of Gevo, to A.E. Innovation, LLC ("A.E.") for $7 million. The transaction includes Agri's 18-million-gallon-per-year ethanol-production facility located in Luverne, Minnesota. Gevo will retain ownership of certain isobutanol-production-related assets and a portion of the vacant land at the site for future use. With these retained assets, Gevo could potentially produce up to 1 million gallons per year of isobutanol, which can be sold as a specialty chemical, or converted into isooctane

      5/28/25 9:00:00 AM ET
      $GEVO
      Major Chemicals
      Industrials
    • Gevo Appoints Industry Veteran James Barber, Ph.D. to Board of Directors

      ENGLEWOOD, Colo., May 27, 2025 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ:GEVO), a leader in sustainable aviation fuel and renewable chemicals, announced today the appointment of James J. Barber, Ph.D., to its Board of Directors. Dr. Barber brings decades of executive leadership and board experience in public and private companies including fuels, chemicals, biobased materials, micro-optics, carbon nanofibers, joint ventures and licensing. Dr. Barber currently serves on the board of directors of Graham Corporation (NYSE:GHM), where he chairs the Compensation Committee and is a member of the Audit and Nomination and Governance Committees. Dr. Barber holds a Ph.D. in Organic Chemistry from the

      5/27/25 4:10:00 PM ET
      $GEVO
      $GHM
      Major Chemicals
      Industrials
      Industrial Machinery/Components

    $GEVO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • CFO Agiri Oluwagbemileke Yusuf sold $12,572 worth of shares (10,810 units at $1.16), decreasing direct ownership by 7% to 152,140 units (SEC Form 4)

      4 - Gevo, Inc. (0001392380) (Issuer)

      6/4/25 5:35:08 PM ET
      $GEVO
      Major Chemicals
      Industrials
    • Chief Advocacy & Comms Officer Fitzgerald Lindsay Clinton sold $10,452 worth of shares (8,987 units at $1.16), decreasing direct ownership by 5% to 161,469 units (SEC Form 4)

      4 - Gevo, Inc. (0001392380) (Issuer)

      6/4/25 5:35:05 PM ET
      $GEVO
      Major Chemicals
      Industrials
    • New insider Agiri Oluwagbemileke Yusuf claimed ownership of 181,950 shares (SEC Form 3)

      3 - Gevo, Inc. (0001392380) (Issuer)

      6/3/25 5:34:48 PM ET
      $GEVO
      Major Chemicals
      Industrials

    $GEVO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Gevo Inc.

      SC 13G/A - Gevo, Inc. (0001392380) (Subject)

      11/12/24 4:02:11 PM ET
      $GEVO
      Major Chemicals
      Industrials
    • Amendment: SEC Form SC 13G/A filed by Gevo Inc.

      SC 13G/A - Gevo, Inc. (0001392380) (Subject)

      11/4/24 11:58:10 AM ET
      $GEVO
      Major Chemicals
      Industrials
    • Amendment: SEC Form SC 13G/A filed by Gevo Inc.

      SC 13G/A - Gevo, Inc. (0001392380) (Subject)

      7/8/24 4:32:39 PM ET
      $GEVO
      Major Chemicals
      Industrials

    $GEVO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Northland Capital initiated coverage on Gevo with a new price target

      Northland Capital initiated coverage of Gevo with a rating of Market Perform and set a new price target of $2.00

      8/21/23 9:21:52 AM ET
      $GEVO
      Major Chemicals
      Industrials
    • UBS initiated coverage on Gevo with a new price target

      UBS initiated coverage of Gevo with a rating of Neutral and set a new price target of $2.25

      12/14/22 7:48:29 AM ET
      $GEVO
      Major Chemicals
      Industrials
    • Jefferies initiated coverage on Gevo with a new price target

      Jefferies initiated coverage of Gevo with a rating of Hold and set a new price target of $2.30

      10/19/22 8:39:11 AM ET
      $GEVO
      Major Chemicals
      Industrials

    $GEVO
    SEC Filings

    See more
    • SEC Form S-8 filed by Gevo Inc.

      S-8 - Gevo, Inc. (0001392380) (Filer)

      6/5/25 7:38:48 PM ET
      $GEVO
      Major Chemicals
      Industrials
    • SEC Form 144 filed by Gevo Inc.

      144 - Gevo, Inc. (0001392380) (Subject)

      6/3/25 4:05:51 PM ET
      $GEVO
      Major Chemicals
      Industrials
    • Gevo Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

      8-K - Gevo, Inc. (0001392380) (Filer)

      5/27/25 4:01:41 PM ET
      $GEVO
      Major Chemicals
      Industrials